|
LGALS8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.971540E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.158400E-03 |
| Normal-vs-Stage2 |
3.233200E-01 |
| Normal-vs-Stage3 |
9.023400E-01 |
| Normal-vs-Stage4 |
8.916200E-01 |
| Stage1-vs-Stage2 |
3.551200E-01 |
| Stage1-vs-Stage3 |
6.927700E-02 |
| Stage1-vs-Stage4 |
1.464560E-01 |
| Stage2-vs-Stage3 |
5.640600E-01 |
| Stage2-vs-Stage4 |
4.826000E-01 |
| Stage3-vs-Stage4 |
8.443400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.444200E-02 |
| Normal-vs-AfricanAmerican |
8.861800E-03 |
| Normal-vs-Asian |
6.182400E-01 |
| Caucasian-vs-AfricanAmerican |
2.844400E-01 |
| Caucasian-vs-Asian |
7.495600E-01 |
| AfricanAmerican-vs-Asian |
4.380200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.081970E-03 |
| Normal-vs-Female |
6.733600E-01 |
| Male-vs-Female |
1.003420E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.221000E-01 |
| Normal-vs-Extreme_Weight |
1.679940E-03 |
| Normal-vs-Obese |
2.096600E-01 |
| Normal-vs-Extreme_Obese |
6.453900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.928840E-01 |
| Normal_Weight-vs-Obese |
8.104200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.896800E-01 |
| Extreme_Weight-vs-Obese |
6.095900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.755000E-01 |
| Obese-vs-Extreme_Obese |
4.081600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.053000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.105600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.396240E-03 |
| Normal-vs-Age(81-100Yrs) |
2.6476000000164E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.662400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.732000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.357730E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.238100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.75168999999586E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.502300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.598600E-03 |
| Normal-VS-Type2 PRCC |
9.905900E-02 |
| Normal-VS-KIRP CIMP |
9.280800E-01 |
| Normal-VS-Unclassified PRCC |
9.068400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.018200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.282640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.563930E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.993000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.650390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.749400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.043900E-02 |
| Normal-vs-N1 |
3.333600E-01 |
| Normal-vs-N2 |
4.179000E-01 |
| N0-vs-N1 |
6.121500E-03 |
| N0-vs-N2 |
7.616400E-01 |
| N1-vs-N2 |
3.810200E-01 |
|
|
